Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles.
- 1Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein Campus, PO Box 17011, Johannesburg, 2028 South Africa.
Abstract
Colorectal cancer (CRC) remains a major clinical challenge due to the persistence of epithelial cell adhesion molecule (EpCAM) positive (+) cancer stem cells (CSCs), which drive tumour relapse, metastasis, and immune evasion. This review highlights a modular nanomedicine construct, EpAb2‑6‑AuNPs‑PPBa, designed for targeted photodynamic therapy (PDT) in CRC. By integrating EpCAM‑specific antibodies (EpAb2‑6), gold nanoparticles (AuNPs) synthesised through plant extracts, and photosensitiser (PS) such as pheophorbide‑a (PPBa). Upon near‑infrared activation, PPBa generates reactive oxygen species (ROS), inducing immunogenic cell death (ICD) characterised by calreticulin exposure, ATP release, and HMGB1 secretion. The system also incorporates surface‑enhanced Raman scattering (SERS) tags for real‑time imaging and circulating tumour cell (CTC) capture. Green synthesis provides biocompatibility and scalability, and antibody guidance enhances tumour specificity. By critically evaluating antibody selection, AuNPs synthesis strategies, and photosensitiser performance, this review situates EpAb2‑6‑AuNPs‑PPBa within the broader perspective of CRC nanotheranostics. Although rigorous in vivo validation and translational studies are necessary, the construct exemplifies a sustainable, multifunctional approach to precision oncology.Graphical abstract
Related
- Chitosan nanoparticles functionalised with protocatechuic acid improve colon-targeted pazopanib delivery with multi-pathway therapeutic regulation and pharmacokinetic optimisation in colorectal cancer
- Complementary cytotoxicity of GD2-targeted photoimmunotherapy and 5-aminolevulinic acid photodynamic therapy in neuroblastoma and osteosarcoma
- Effects of Antimicrobial Photodynamic Therapy Mediated by Free Curcumin and Curcumin-Associated Superparamagnetic Iron Oxide Nanoparticles on Candida spp. and Microcosm Biofilms Associated with Denture Stomatitis
- Anionic Star-Like Copolymers Based Nanosystems with Gold Nanoparticles and Temoporfin for Photodynamic Therapy of Carcinoma Cell Lines in vitro
- Glutamine-Functionalized mRNA Lipid Nanoparticles Block HIF-1α-Dependent Glycolytic Adaptation to Sensitize Azelaic Acid Therapy in Colorectal Cancer
BibTeX
@article{broni2026targeted,
title = {{Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles.}},
author = {Fermin K Broni and Blassan P George and Heidi Abrahamse},
journal = {Discover oncology},
year = {2026},
month = jul,
doi = {10.1007/s12672-026-05651-4},
url = {https://europepmc.org/article/MED/42926737},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Targeted photodynamic therapy for colorectal cancer using antibody-conjugated green-synthesised nanoparticles.
AU - Fermin K Broni
AU - Blassan P George
AU - Heidi Abrahamse
PY - 2026
DA - 2026/07/01
JO - Discover oncology
DO - 10.1007/s12672-026-05651-4
UR - https://europepmc.org/article/MED/42926737
AB - Colorectal cancer (CRC) remains a major clinical challenge due to the persistence of epithelial cell adhesion molecule (EpCAM) positive (+) cancer stem cells (CSCs), which drive tumour relapse, metastasis, and immune evasion. This review highlights a modular nanomedicine construct, EpAb2‑6‑AuNPs‑PPBa, designed for targeted photodynamic therapy (PDT) in CRC. By integrating EpCAM‑specific antibodies (EpAb2‑6), gold nanoparticles (AuNPs) synthesised through plant extracts, and photosensitiser (PS) such as pheophorbide‑a (PPBa). Upon near‑infrared activation, PPBa generates reactive oxygen species (ROS), inducing immunogenic cell death (ICD) characterised by calreticulin exposure, ATP release, and HMGB1 secretion. The system also incorporates surface‑enhanced Raman scattering (SERS) tags for real‑time imaging and circulating tumour cell (CTC) capture. Green synthesis provides biocompatibility and scalability, and antibody guidance enhances tumour specificity. By critically evaluating antibody selection, AuNPs synthesis strategies, and photosensitiser performance, this review situates EpAb2‑6‑AuNPs‑PPBa within the broader perspective of CRC nanotheranostics. Although rigorous in vivo validation and translational studies are necessary, the construct exemplifies a sustainable, multifunctional approach to precision oncology.Graphical abstract
SN - 2730-6011
ER -